Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General host cancer cell machinery is a broad, non-specific term referring to the collective biological processes and molecular components that sustain the growth, survival, and proliferation of malignant cells within a host (Hanahan & Weinberg, 2011). This encompasses fundamental cellular operations such as DNA replication, transcription, translation, and metabolic pathways that are often dysregulated or hijacked in cancer to support uncontrolled expansion (NCI, 2024). Because this term describes a complex system of pathways rather than a single molecular entity like a receptor or enzyme, it is not classified as a specific therapeutic target in modern drug discovery. Traditional cytotoxic chemotherapies, such as antimetabolites and microtubule inhibitors, interact with various components of this machinery to induce cell death or arrest the cell cycle (ACS, 2023). However, because these processes are also essential for the function of healthy cells, targeting the general machinery often results in significant systemic toxicity and a narrow therapeutic index.
Disruption of fundamental cellular processes including DNA synthesis, microtubule assembly, and metabolic homeostasis to inhibit rapid cell division.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General host cancer cell machinery.